American Thoracic Society International Conference 2025 (ATS 2025)

San Francisco, California, US 16 May 2025 - 21 May 2025

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025 by

The bispecific antibody gremubamab, which targets two proteins on the surface of Pseudomonas aeruginosa, has been shown to substantially reduce bacterial load and improve quality of life for infected bronchiectasis patients in the phase II GREAT-2 study.

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025 by

The use of methotrexate as a first line of treatment for patients with pulmonary sarcoidosis delivers similar efficacy to prednisone as measured by forced vital capacity after 24 weeks, results of the PREDMETH trial have shown.

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025 by

A novel digital psychological therapy, named Almee, demonstrates efficacy in improving health-related quality of life (HRQOL) in patients with pulmonary fibrosis, irrespective of antifibrotic treatment use, reports a study presented at ATS 2025.

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025

BGF initiation after an exacerbation in COPD: Does timing matter?

06 Jun 2025 by

Findings from the MITOS EROS+CP (US) study underscore the importance of prompt initiation of budesonide/glycopyrrolate/formoterol fumarate (BGF) following an exacerbation in patients with chronic obstructive pulmonary disease (COPD).

BGF initiation after an exacerbation in COPD: Does timing matter?

06 Jun 2025

WAYFINDER updates boost tezepelumab role in OCS-dependent severe asthma

03 Jun 2025 by

Updated results from the open-label, phase IIIb WAYFINDER study continue to support the oral corticosteroid (OCS)-sparing efficacy of tezepelumab in the treatment of patients with OCS-dependent severe asthma.

WAYFINDER updates boost tezepelumab role in OCS-dependent severe asthma

03 Jun 2025

COPD detection refined with new diagnostic schema

02 Jun 2025 by

Incorporating spirometry with respiratory symptoms and quality of life and structural lung abnormalities on CT imaging to meet criteria for a chronic obstructive pulmonary disease (COPD) diagnosis spots additional patients at risk of poor respiratory outcomes, according to the results of a study presented at the ATS annual meeting and simultaneously published in JAMA.

COPD detection refined with new diagnostic schema

02 Jun 2025